Mepolizumab for treating severe eosinophilic asthma

Register of interests (PDF 154 KB)

Equality Impact Assessment (Guidance development) (PDF 141 KB)

Final draft guidance

Final appraisal document (PDF 189 KB)

Committee papers (PDF 5.55 MB)

Public committee slides (PDF 820 KB)

Final stakeholder list (PDF 157 KB)

Final scope (PDF 176 KB)

Equality impact assessment (Scoping) (PDF 124 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 188 KB)

Consultation document (PDF 176 KB)

Provisional Stakeholder List (post-referral) (PDF 157 KB)

Final appraisal document - TA431 (PDF 166 KB)

Committee papers (FAD) - TA431 (PDF 3.01 MB)

Public committee slides (FAD) - TA431 (PDF 1.11 MB)

Final appraisal document - equality impact assessment - TA431 (PDF 264 KB)

Appraisal consultation document (PDF version) (ACD2) - TA431 (PDF 2.09 MB)

Committee papers (ACD2) - TA431 (PDF 234 KB)

Appraisal consultation document (PDF version) (ACD1) - TA431 (PDF 6.45 MB)

Committee papers (ACD1) - TA431 (PDF 267 KB)